Itolizumab for Acute Graft-Versus-Host Disease

Itolizumab for Acute Graft-Versus-Host Disease The EQUATE study is a Phase 1b trial to evaluate the safety and clinical efficacy of itolizumab for front-line treatment in patients who present with aGVHD.

The study is an open-label dose escalation study in adult patients who present with high risk aGVHD who typically respond poorly to steroids. Patients in this study received up to a total of 5 doses of itolizumab, administered bi-weekly over the course of 10 weeks. The Phase 1b data was presented to the FDA to inform the path forward for the aGVHD program, and the company is now in Pivotal Phase 3 planning and expected to be ready for enrollment in Q4 2021.

After going through a rigorous vetting process, Equillium is excited to announce that our EQUATOR study in aGVHD, was se...
07/11/2022

After going through a rigorous vetting process, Equillium is excited to announce that our EQUATOR study in aGVHD, was selected to be featured on the Be The Match Jason Carter Clinical Trials Search & Support website! https://ctsearchsupport.org/clinical_trials/featured

05/24/2022

The Scars You Can't See are the Hardest to Heal

May is Mental Health Awareness Month - a perfect time to share with you a few mental health resources we've designed specifically for transplant recipients and their loved ones.

Studies show that distress, anxiety, depression and post-traumatic stress disorder (PTSD) are higher among transplant recipients than the general population. These problems affect caregivers as well.

What can you do if you're feeling distressed or sad?

Don't Be Too Hard on Yourself

"Allow yourself space to grieve what you've lost as a result of getting sick and needing a transplant," says Katie Schoeppner, Director of Patients Services at Be The Match.

"With how life-impacting this treatment is, it's really normal to feel grief. And it's important to be gentle with yourself."

Be honest with others about your emotional struggles; seek support from other transplant recipients; and find a mental health counselor - these are just a few strategies Katie offered at one of BMT InfoNet's survivorship symposium. Click the button below to listen to her talk and read the transcript.
Riding the Emotional Roller Coaster of BMT Survivorship: https://www.bmtinfonet.org/video

05/24/2022

A road map for managing GVHD



At the Graft-versus-Host Disease Clinic at MD Anderson Cancer Center in Houston, Texas, patients learn three rules:

Know thyself (examine your body frequently for signs of GVHD)

Know thy foe (know the signs and symptoms of GVHD)

Make sure thy self is never thy foe (take your medications and follow your doctor's care instructions carefully)

In this new video from BMT InfoNet's 2022 Survivorship Symposium:

Introduction to Graft-versus-Host Disease with Dr. Amin Alousi, head of the MD Anderson GVHD Clinic, describes the many ways GVHD can affect your skin, mouth, eyes, ge****ls, GI tract, joints, fascia, liver and lungs.

View Video, Transcript and Slides
www.bmtinfonet.org/videos

05/16/2022
Thank you BMTInfoNet for a fantastic Survivorshii Synposiun!
05/10/2022

Thank you BMTInfoNet for a fantastic Survivorshii Synposiun!

Another great day of learning from BMTInfoNet Survivorship symposium!
05/05/2022

Another great day of learning from BMTInfoNet Survivorship symposium!

Celebrating a Second Chance at Life
Survivorship Symposium
https://symposium.bmtinfonet.org/

05/04/2022

A BIG thank you to our sponsors--corporate, transplant centers and advocacy organizations--The 2022 Celebrating a Second Chance at Life Survivorship Symposium starts tomorrow and runs through May 6th!

Registration is still open: https://lnkd.in/eXcD7RGc Join virtually 1800+ blood stem cell transplant survivors and their caregivers for expert-led educational sessions that will help you take charge of your long-term health.

Today, is day three of the BMTInfoNet Survivorship Symposium. You can learn still register and view the prior sessions! ...
05/02/2022

Today, is day three of the BMTInfoNet Survivorship Symposium. You can learn still register and view the prior sessions!

Times listed for the workshops are in central time zone Gain access to all the live and recorded workshops Saturday, April 30, 2022 11:00 AM Central Time View Welcoming Remarks and Keynote Address Welcome: Susan Stewart, Executive Director and Founder, BMT InfoNet Presenter: Heather Harpham MA, MFA,...

Looking forward to the BMTInfoNet Survivorship Symposium starting tomorrow, through May 6th. You can learn more here. ht...
04/29/2022

Looking forward to the BMTInfoNet Survivorship Symposium starting tomorrow, through May 6th. You can learn more here. https://symposium.bmtinfonet.org/

Image Celebrating a Second Chance at Life Symposium April 30 - May 6, 2022 A week packed full of information, inspiration and community. Choose from 36 workshops and learn from our distinguished panel of speakers how to manage the many medical, psychosocial and physical challenges that can arise aft...

Address

San Diego, CA

Alerts

Be the first to know and let us send you an email when Itolizumab for Acute Graft-Versus-Host Disease posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Itolizumab for Acute Graft-Versus-Host Disease:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram